Julien Grassot, PhD, is the Head of Biostatistics and Clinical Development at PK MED. He leverages his expertise in biomathematics, clinical development, and regulatory submissions for health authorities like the FDA and EMA. He holds a PhD from Université Claude Bernard Lyon 1 and previously contributed to Johnson & Johnsons COVID-19 vaccine team.
He is a co-inventor on multiple patents for modified-release drug formulations, specifically for gamma-hydroxybutyrate, designed to improve pharmacokinetics and treat conditions like narcolepsy.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.